Phoenix Transplant & Vascular Surgeon Ltd is categorized under Cardiologists in Phoenix, AZ and active since 1978.
Phoenix Transplant & Vascular Surgeon Ltd was established in 1978, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Cardiologists business, which does work in the B2C market, and is classified as a Cardiologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ben A Vanderwerf at the company’s single location by writing to 1300 North 12th St # 404, Phoenix, Arizona AZ 85006 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Phoenix Transplant & Vascular Surgeon Ltd |
| Contact Person: | Ben A Vanderwerf |
| Address: | 1300 North 12th St # 404, Phoenix, Arizona 85006 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1978 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Cardiologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Phoenix Transplant & Vascular Surgeon Ltd was started in 1978 to provide professional Cardiologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ben A Vanderwerf for inquiries that concern Phoenix Transplant & Vascular Surgeon Ltd by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Phoenix Transplant & Vascular Surgeon Ltd can be found at the coordinates 33.4631,-112.056534 as well as the street address 1300 North 12th St # 404 in Phoenix, Arizona 85006.
For its online presence, you may visit Phoenix Transplant & Vascular Surgeon Ltd’s website at and engage with its social media outlets through on Twitter and on Facebook.